← ANALYST RATINGS · TIPRANKS
Conmed (CNMD): analyst forecast and price target
Analyst consensus
Hold0 Buy3 Hold1 Sell
Ratings of 4 analysts in the last 3 months · top analysts only12-month forecast
Based on 4 price targets given in the last 3 months, the average target is $45.50, the highest $46.00, the lowest $45.00. The average is −2.6% from the last price of $46.72.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $57.00 → $50.00−12.3% | Buy | +7.0% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $55.00 → $48.00−12.7% | Hold | +2.7% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $54.00 → $48.00−11.1% | Hold | +2.7% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $52.00 → $46.00−11.5% | Hold | −1.5% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $57.00 → $50.00−12.3% | Buy | +7.0% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $56.00 → $49.00−12.5% | Buy | +4.9% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| Travis Steed★★★★★★★★★★#3596 · hits 53% · avg +3.0% | Bank of America Securities | — | Sell | — | Reiterated | 30.07.26on TipRanks 13:13 | +7.0%next day −2.2% · 5 days +2.3% | ↗ |
| Robbie Marcus★★★★★★★★★★#1974 · hits 51% · avg +6.5% | J.P. Morgan | $40.00 → $45.00+12.5% | Hold | −3.7% | Assigned | 30.07.26on TipRanks 09:25 | +7.0%next day −2.2% · 5 days +2.3% | ↗ |
| Larry Biegelsen★★★★★★★★★★#2729 · hits 53% · avg +3.8% | Wells Fargo | $39.00 → $46.00+17.9% | Hold | −1.5% | Reiterated | 30.07.26on TipRanks 07:11 | +7.0%next day −2.2% · 5 days +2.3% | ↗ |
| Matthew O'Brien★★★★★★★★★★#12031 · hits 41% · avg −4.5% | Piper Sandler | $39.00 → $45.00+15.4% | Hold | −3.7% | Reiterated | 30.07.26on TipRanks 06:57 | +7.0%next day −2.2% · 5 days +2.3% | ↗ |
| Michael Matson★★★★★★★★★★#1853 · hits 50% · avg +6.0% | Needham | — | Hold | — | Reiterated | 30.07.26on TipRanks 05:47 | +7.0%next day −2.2% · 5 days +2.3% | ↗ |
| Vik Chopra★★★★★★★★★★#6076 · hits 45% · avg +1.9% | BMO Capital | $36.00 → $45.00+25.0% | Hold | −3.7% | Reiterated | 29.07.26on TipRanks Jul 30 07:57 | −0.8%next day +7.0% · 5 days +8.6% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Conmed
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $45.25 at a price of $46.23 (−2.1%); now: $45.25 at $46.72 (−3.1%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 3 | 7 | 6 | 6 | 0 |
| Sell | 0 | 1 | 2 | 2 | 1 | 0 |
Earnings and sales forecast
Next report: 28.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $1.00 (from $0.99 to $1.02). Last quarter: $1.38.
Sales
Next quarter’s sales estimate — $336M (from $335M to $337M). Last quarter: $344M.
Best top-analyst consensus in the sector · Healthcare
About Conmed
- CEO: Patrick J. Beyer
- Employees: 3,900
- 11311 Concept Boulevard, Largo, FL, 33773, US
- www.conmed.com
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.
Data from the stock’s TipRanks forecast page, read 19 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗